{"transactions":[{"id":869999,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-03T12:19:33.000Z","date":"2026-02-28","kind":"exercise","planned":false,"acquired":false,"shares":202260,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":404520,"derivative":{"underlying":"Common Stock","underlying_shares":202260},"source":{"system":"sec-edgar","filing":"0001062822-26-000039","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000039/form4.xml","form_type":"4"}},{"id":869998,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-03T12:19:33.000Z","date":"2026-02-28","kind":"exercise","planned":false,"acquired":false,"shares":74226,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":74227,"derivative":{"underlying":"Common Stock","underlying_shares":74226},"source":{"system":"sec-edgar","filing":"0001062822-26-000039","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000039/form4.xml","form_type":"4"}},{"id":869997,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-03T12:19:33.000Z","date":"2026-02-28","kind":"exercise","planned":false,"acquired":false,"shares":35790,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":35790},"source":{"system":"sec-edgar","filing":"0001062822-26-000039","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000039/form4.xml","form_type":"4"}},{"id":869996,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-03T12:19:33.000Z","date":"2026-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":109098,"price":1.47,"value":160374.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto."}],"balance_after":323430,"source":{"system":"sec-edgar","filing":"0001062822-26-000039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000039/form4.xml","form_type":"4"}},{"id":869995,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-03T12:19:33.000Z","date":"2026-02-28","kind":"exercise","planned":false,"acquired":true,"shares":202260,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":432528,"source":{"system":"sec-edgar","filing":"0001062822-26-000039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000039/form4.xml","form_type":"4"}},{"id":869994,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-03T12:19:33.000Z","date":"2026-02-28","kind":"exercise","planned":false,"acquired":true,"shares":74226,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":230268,"source":{"system":"sec-edgar","filing":"0001062822-26-000039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000039/form4.xml","form_type":"4"}},{"id":869993,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-03T12:19:33.000Z","date":"2026-02-28","kind":"exercise","planned":false,"acquired":true,"shares":35790,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":156042,"source":{"system":"sec-edgar","filing":"0001062822-26-000039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000039/form4.xml","form_type":"4"}},{"id":901912,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-17T21:09:31.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":519920,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter."}],"balance_after":519920,"derivative":{"exercise_price":1.37,"expiration_date":"2036-02-12","underlying":"Common Stock","underlying_shares":519920},"source":{"system":"sec-edgar","filing":"0001062822-26-000024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000024/form4.xml","form_type":"4"}},{"id":901911,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-17T21:09:31.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":346610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":346610,"derivative":{"underlying":"Common Stock","underlying_shares":346610},"source":{"system":"sec-edgar","filing":"0001062822-26-000024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000024/form4.xml","form_type":"4"}},{"id":1236709,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-03T21:31:11.000Z","date":"2025-02-28","kind":"exercise","planned":false,"acquired":false,"shares":74227,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":148453,"derivative":{"underlying":"Common Stock","underlying_shares":74227},"source":{"system":"sec-edgar","filing":"0001127602-25-007530","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225007530/form4.xml","form_type":"4"}},{"id":1236708,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-03T21:31:11.000Z","date":"2025-02-28","kind":"exercise","planned":false,"acquired":false,"shares":35790,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":35790,"derivative":{"underlying":"Common Stock","underlying_shares":35790},"source":{"system":"sec-edgar","filing":"0001127602-25-007530","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225007530/form4.xml","form_type":"4"}},{"id":1236707,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-03T21:31:11.000Z","date":"2025-02-28","kind":"exercise","planned":false,"acquired":false,"shares":27917,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":27917},"source":{"system":"sec-edgar","filing":"0001127602-25-007530","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225007530/form4.xml","form_type":"4"}},{"id":1236706,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-03-03T21:31:11.000Z","date":"2025-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":65308,"price":0.67,"value":43756.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto."}],"balance_after":120252,"source":{"system":"sec-edgar","filing":"0001127602-25-007530","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225007530/form4.xml","form_type":"4"}},{"id":1236705,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-03-03T21:31:11.000Z","date":"2025-02-28","kind":"exercise","planned":false,"acquired":true,"shares":74227,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":185560,"source":{"system":"sec-edgar","filing":"0001127602-25-007530","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225007530/form4.xml","form_type":"4"}},{"id":1236704,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-03-03T21:31:11.000Z","date":"2025-02-28","kind":"exercise","planned":false,"acquired":true,"shares":35790,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":111333,"source":{"system":"sec-edgar","filing":"0001127602-25-007530","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225007530/form4.xml","form_type":"4"}},{"id":1236703,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-03-03T21:31:11.000Z","date":"2025-02-28","kind":"exercise","planned":false,"acquired":true,"shares":27917,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":75543,"source":{"system":"sec-edgar","filing":"0001127602-25-007530","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225007530/form4.xml","form_type":"4"}},{"id":1264746,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-18T21:20:42.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":606780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":606780,"derivative":{"underlying":"Common Stock","underlying_shares":606780},"source":{"system":"sec-edgar","filing":"0001127602-25-005220","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225005220/form4.xml","form_type":"4"}},{"id":1264745,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-18T21:20:42.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":910170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter."}],"balance_after":910170,"derivative":{"exercise_price":0.695,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":910170},"source":{"system":"sec-edgar","filing":"0001127602-25-005220","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225005220/form4.xml","form_type":"4"}},{"id":1610694,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2024-02-29T21:28:56.000Z","date":"2024-02-28","kind":"exercise","planned":false,"acquired":false,"shares":35790,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":71580,"derivative":{"underlying":"Common Stock","underlying_shares":35790},"source":{"system":"sec-edgar","filing":"0001127602-24-007618","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224007618/form4.xml","form_type":"4"}},{"id":1610693,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2024-02-29T21:28:56.000Z","date":"2024-02-28","kind":"exercise","planned":false,"acquired":false,"shares":27916,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":27917,"derivative":{"underlying":"Common Stock","underlying_shares":27916},"source":{"system":"sec-edgar","filing":"0001127602-24-007618","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224007618/form4.xml","form_type":"4"}},{"id":1610692,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-29T21:28:56.000Z","date":"2024-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":31265,"price":2.62,"value":81914.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto."}],"balance_after":47626,"source":{"system":"sec-edgar","filing":"0001127602-24-007618","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224007618/form4.xml","form_type":"4"}},{"id":1610691,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-29T21:28:56.000Z","date":"2024-02-28","kind":"exercise","planned":false,"acquired":true,"shares":35790,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":78891,"source":{"system":"sec-edgar","filing":"0001127602-24-007618","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224007618/form4.xml","form_type":"4"}},{"id":1610690,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-29T21:28:56.000Z","date":"2024-02-28","kind":"exercise","planned":false,"acquired":true,"shares":27916,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":43101,"source":{"system":"sec-edgar","filing":"0001127602-24-007618","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224007618/form4.xml","form_type":"4"}},{"id":1649934,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-12T21:14:52.000Z","date":"2024-02-08","kind":"grant","planned":false,"acquired":true,"shares":222680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter."}],"balance_after":222680,"derivative":{"exercise_price":2.15,"expiration_date":"2034-02-08","underlying":"Common Stock","underlying_shares":222680},"source":{"system":"sec-edgar","filing":"0001127602-24-004462","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224004462/form4.xml","form_type":"4"}},{"id":1649933,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2024-02-12T21:14:52.000Z","date":"2024-02-08","kind":"grant","planned":false,"acquired":true,"shares":222680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":222680,"derivative":{"underlying":"Common Stock","underlying_shares":222680},"source":{"system":"sec-edgar","filing":"0001127602-24-004462","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224004462/form4.xml","form_type":"4"}},{"id":1984584,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-01T21:50:54.000Z","date":"2023-02-28","kind":"exercise","acquired":false,"shares":27917,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":55833,"derivative":{"underlying":"Common Stock","underlying_shares":27917},"source":{"system":"sec-edgar","filing":"0001127602-23-007923","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223007923/form4.xml","form_type":"4"}},{"id":1984583,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-01T21:50:54.000Z","date":"2023-02-28","kind":"tax_withholding","acquired":false,"shares":12732,"price":2.17,"value":27628.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto."}],"balance_after":15185,"source":{"system":"sec-edgar","filing":"0001127602-23-007923","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223007923/form4.xml","form_type":"4"}},{"id":1984582,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-01T21:50:54.000Z","date":"2023-02-28","kind":"exercise","acquired":true,"shares":27917,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":27917,"source":{"system":"sec-edgar","filing":"0001127602-23-007923","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223007923/form4.xml","form_type":"4"}},{"id":2020604,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-13T21:59:05.000Z","date":"2023-02-09","kind":"grant","acquired":true,"shares":322110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter."}],"balance_after":322110,"derivative":{"exercise_price":2.43,"expiration_date":"2033-02-09","underlying":"Common Stock","underlying_shares":322110},"source":{"system":"sec-edgar","filing":"0001127602-23-004928","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223004928/form4.xml","form_type":"4"}},{"id":2020603,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-13T21:59:05.000Z","date":"2023-02-09","kind":"grant","acquired":true,"shares":107370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":107370,"derivative":{"underlying":"Common Stock","underlying_shares":107370},"source":{"system":"sec-edgar","filing":"0001127602-23-004928","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223004928/form4.xml","form_type":"4"}},{"id":2398982,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-14T21:04:13.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":83750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":83750,"derivative":{"underlying":"Common Stock","underlying_shares":83750},"source":{"system":"sec-edgar","filing":"0001127602-22-004759","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222004759/form4.xml","form_type":"4"}},{"id":2398981,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-14T21:04:13.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":251250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter."}],"balance_after":251250,"derivative":{"exercise_price":3.2,"expiration_date":"2032-02-10","underlying":"Common Stock","underlying_shares":251250},"source":{"system":"sec-edgar","filing":"0001127602-22-004759","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222004759/form4.xml","form_type":"4"}},{"id":2618462,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63545,"kind":"person","name":"Granowitz Craig B","position":1,"cik":"0001876655","reported_name":"Granowitz Craig B","relationship":{"officer":true,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-03T20:39:28.000Z","date":"2021-08-02","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (8/2/2022) and vests 1/48th per month for each month of service thereafter."}],"balance_after":250000,"derivative":{"exercise_price":3.54,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001127602-21-022954","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221022954/form4.xml","form_type":"4"}}]}